Brand
Where The Injured Go To Protect Their Rights

Claiming SSDI for rare diseases can be challenging

| Oct 3, 2017 | Social Security Disability Insurance |

Applying for Social Security Disability Insurance is a complicated process to navigate. If the claim is based upon contracting a rare disease, it could be even more challenging. There are thousands of rare diseases, and disability benefits may be a great help for individuals with rare disorders. SSDI is a program offered by the federal government, providing financial assistance for families or individuals in need.

Any California resident who is diagnosed with a rare disease that is debilitating, preventing him or her from working may be entitled to apply for SSDI benefits. To qualify, the applicant must be totally disabled, and the condition must be permanent. For each rare disorder, the Social Security Administration has different requirements. These are divided into categories by location in the victim’s body along with the severity of the disease.

Certain technical requirements related to the applicant’s Social Security contributions during years of employment will also have to be met. While SSDI applicants typically have to wait for many months before they know whether they were found eligible for benefits, certain severe and rare diseases may qualify immediately. These are the disorders that qualify under the Compassionate Allowances programs.

Californians suffering from rare disorders may find the application process for SSDI overwhelming. This is where the skills of an attorney who is experienced in dealing with these insurance claims can be invaluable. A lawyer can assist with the application and navigate the entire process on behalf of the client. A person who has experienced legal counsel to handle the administrative processes along with the necessary hearings on his or her behalf will likely be at a significant advantage.

Source: raredr.com, “Qualifying for Social Security Disability Benefits with a Rare Disease”, Bryan Mac Murray, Accessed on Sept. 15, 2017